Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Shigeru Ohshima"'
Autor:
Shinji Oshima, Mari Yamagishi, Mitsuyoshi Okita, Hayato Akimoto, Akio Negishi, Norimitsu Horii, Mizue Mutoh, Yasuko Sannomaru, Sachihiko Numajiri, Naoko Inoue, Shigeru Ohshima, Masahiro Wada, Daisuke Kobayashi
Publikováno v:
SAGE Open Medicine, Vol 7 (2019)
Objectives: In 2014, immediately prior to the revision of Article 25-2 of the Pharmacists’ Act, we conducted a survey on pharmacists’ and patients’ perceptions of pharmacists’ roles. A role discrepancy between the two was identified. The obje
Externí odkaz:
https://doaj.org/article/dd51163741314490bb1c01cd6b098647
Autor:
Tsuyoshi Ebihara, MS, Shinji Oshima, PhD, Mitsuyoshi Okita, MS, Sayumi Shiina, MS, Akio Negishi, BS, Kousuke Ohara, BS, Shigeru Ohshima, PhD, Hiroyuki Iwasaki, MD, Akira Yoneyama, MD, Eiji Kitazumi, MD, Daisuke Kobayashi, PhD
Publikováno v:
Current Therapeutic Research, Vol 77, Iss C, Pp 7-13 (2015)
Background: Pneumonia is the most common cause of death in patients with severe motor and intellectual disabilities (SMID), and intravenous ceftazidime (CAZ) is a widely used treatment for such infections. However, intravenous administration in patie
Externí odkaz:
https://doaj.org/article/da71d51b8d1c49c08d28bfdcbf5c1220
Autor:
Hayato Akimoto, Shinji Oshima, Akio Negishi, Kousuke Ohara, Shigeru Ohshima, Naoko Inoue, Daisuke Kobayashi
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163583 (2016)
Smoking Cessation Treatment (SCT) is a policy that has to be promoted for health economics, and expectations for the success of treatments with varenicline (VAR) are large. However, the Food and Drug Administration (FDA) have issued a warning on VAR-
Externí odkaz:
https://doaj.org/article/26f9a74342ef4434bfd6616a10a8c9ae
Autor:
Shigeru Ohshima, Mitsuko Ohashi-Suzuki, Yutaka Miura, Yoshisada Yabu, Noriko Okada, Nobuo Ohta, Takashi Suzuki
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e15577 (2010)
Flagellum-mediated motility of Trypanosoma brucei is considered to be essential for the parasite to complete stage development in the tsetse fly vector, while the mechanism by which flagellum-mediated motility is controlled are not fully understood.
Externí odkaz:
https://doaj.org/article/8cba6c6016e54dee97e94f130da3e3eb
Autor:
Akio Negishi, Shinji Oshima, Mizue Mutoh, Norimitsu Horii, Naoko Inoue, Sachihiko Numajiri, Shigeru Ohshima, Daisuke Kobayashi
Publikováno v:
International Journal of Medical Sciences. 19:1816-1823
Adverse drug events due to drug-drug interactions can be prevented by avoiding concomitant use of causative drugs; therefore, it is important to understand drug combinations that cause drug-drug interactions. Although many attempts to identify drug-d
Autor:
Norimitsu Horii, Akio Negishi, Shinji Oshima, Shigeru Ohshima, Naoko Inoue, Mizue Mutoh, Daisuke Kobayashi, Sachihiko Numajiri
Publikováno v:
Biological and Pharmaceutical Bulletin. 44:932-936
The “INTERACTIONS” section of package inserts aims to provide alert-type warnings in clinical practice; however, these also include many drug–drug interactions that occur rarely. Moreover, considering that drug–drug interaction alert systems
Autor:
Takayuki Ohtsuki, Shigeru Ohshima, Shigekazu Takahashi, Akira Uchida, Umpei Nagashima, Atsuko Nishigaki
Publikováno v:
Bulletin of the Chemical Society of Japan. 94:418-426
The native water-soluble chlorophyll protein, CP663, extracted from Lepidium virginicum, consists of four subunits, each with one chlorophyll (Chl), and the four Chls form two dimers in an orthogon...
Autor:
Shigeru Ohshima, Sachihiko Numajiri, Akio Negishi, Shinji Oshima, Naoko Inoue, Daisuke Kobayashi, Mizue Mutoh, Norimitsu Horii
Publikováno v:
Drugs-Real World Outcomes
Background Pharmacokinetics and pharmacodynamics of drugs in elderly individuals differ from those in younger adults;thus, adverse drug events (ADEs) are common in older patients with polypharmacy because co-existing comorbidities elevate the risk of
Autor:
Yukio Ozaki, Jiro Aoki, Atsushi Hirohata, Shiro Uemura, Nobuaki Kokubu, Satoru Suwa, Ken Kozuma, Kazuhito Hirata, Kazuo Kimura, Kunihiro Nishimura, Teruo Noguchi, Kenichi Tsujita, Shigeru Ohshima, Taishi Okuno, Yoshisato Shibata, Hiroshi Funayama, Wataru Shimizu, Tetsuya Tobaru, Hisao Ogawa, Yoshihiro Miyamoto, Teruo Inoue, Yasuharu Nakama, Masaharu Ishihara, Mafumi Owa, Keijiro Saku, Koichi Nakao, Junya Ako, Toshiaki Mano, Kengo Tanabe, Takashi Morita, Yasuhiro Morita, Yoshihiko Saito, Atsunori Okamura, Kazuteru Fujimoto, Satoshi Yasuda
Publikováno v:
Heart and Vessels. 34:1899-1908
It is known that incidence and short-term mortality rate of acute myocardial infarction (AMI) tend to be higher in the cold season. The aim of our study was to investigate the association of onset-season with patient characteristics and long-term pro
Autor:
Yukio Ozaki, Jiro Aoki, Yoshihiro Miyamoto, Keijiro Saku, Kenichi Tsujita, Masaharu Ishihara, Teruo Inoue, Yoshisato Shibata, Atsushi Hirohata, Hisao Ogawa, Satoru Suwa, Mafumi Owa, Ken Kozuma, Shiro Uemura, Wataru Shimizu, Teruo Noguchi, Shigeru Ohshima, Atsunori Okamura, Kazuteru Fujimoto, Yasuharu Nakama, Kengo Tanabe, Tetsuya Tobaru, Koichi Nakao, Satoshi Yasuda, Yoshihiko Saito, Takashi Morita, Kazuhito Hirata, Kazuo Kimura, Kunihiro Nishimura, Taishi Okuno, Junya Ako, Toshiaki Mano, Nobuaki Kokubu, Yasuhiro Morita, Hiroshi Funayama
Publikováno v:
Circulation Journal. 83:1054-1063
Beta-blockers are standard therapy for acute myocardial infarction (AMI). However, despite current advances in the management of AMI, it remains unclear whether all AMI patients benefit from β-blockers. We investigated whether admission heart rate (